Mustang Bio Inc. (MBIO) is a clinical-stage biopharmaceutical company focused on developing gene therapies and other cell-based therapeutics. Its pipeline includes therapies for genetic diseases, oncology, and autoimmune disorders. Mustang Bio has several partnerships with other biotech and pharmaceutical companies to develop and commercialize its therapies. The company is headquartered in Worcester, Massachusetts, and was founded in 2015.
Mustang Bio Inc. (MBIO) is a clinical-stage biopharmaceutical company focused on developing gene therapies and other cell-based therapeutics. Its pipeline includes therapies for genetic diseases, oncology, and autoimmune disorders. Mustang Bio has several partnerships with other biotech and pharmaceutical companies to develop and commercialize its therapies. The company is headquartered in Worcester, Massachusetts, and was founded in 2015.